Here are this week’s top news stories, as reported on PharmExec.com:

FDA Puts Kibosh on DTC User Fee Program
In a surprising but not completely unexpected move, FDA announced last week that its DTC user fee program was dead on arrival. Feds cite lack of funding as main reason.
Click to read more>>>

Vytorin Study Causes Media Stir, but Are the Concerns Justified?
Unlike Vioxx, Vytorin works exactly as explained in its now-famous food-and-family ads. So why are people up in arms against the drug? Experts ponder what went wrong.
Click to read more>>>

Novartis Takes Top Spot in Managed Care Audit–Again
Managed care pharmacy executives list their favorite pharmaceutical companies based on promotional activities and the ability to meet managed care needs. Novartis reigns for 11th straight quarter.
Click to read more>>>